BMSEED, LLC
Medtech · Private
Microfluidic chip-based platform with stretchable microelectrode arrays for 3D in vitro modeling of Alzheimer's disease and traumatic brain injury
- Grants
- $5.0M
- 14 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 2 granted · 0 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Lab-To-Marketplace: Commercialization of a stretchable microelectrode array | $201,226 | |
| Federal grant | Department of Health and Human Services · Phase I · Lab-To-Marketplace: Commercialization of a stretchable microelectrode array | $25,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a large area high resolution micro ECoG electrode array | $329,540 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a large area high resolution micro ECoG electrode array | $49,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a large area high resolution micro ECoG electrode array | $189,443 | |
| Federal grant | Department of Health and Human Services · Phase II · Lab-To-Marketplace: Commercialization of a stretchable microelectrode array | $796,856 | |
| Federal grant | Department of Health and Human Services · Phase II · Lab-To-Marketplace: Commercialization of a stretchable microelectrode array | $689,298 | |
| Federal grant | Department of Health and Human Services · Phase II · Lab-To-Marketplace: Commercialization of a stretchable microelectrode array | $95,200 | |
| Federal grant | Department of Health and Human Services · Phase II · Lab-To-Marketplace: Commercialization of a stretchable microelectrode array | $95,200 | |
| Federal grant | Department of Health and Human Services · Phase I · The first adaptable, 3D-formfitting microelectrode array for organoid-based models of neurological and neurodegenerative diseases | $419,641 | |
| Federal grant | Department of Health and Human Services · Phase I · The first adaptable, 3D-formfitting microelectrode array for organoid-based models of neurological and neurodegenerative diseases | $55,000 | |
| Federal grant | Department of Health and Human Services · Phase II · A physiologically relevant pre-clinical drug screening platform for Alzheimer's Disease and Traumatic Brain Injury with integrated stretchable microelectrodes | $449,997 | |
| Federal grant | Department of Health and Human Services · Phase II · A physiologically relevant pre-clinical drug screening platform for Alzheimer's Disease and Traumatic Brain Injury with integrated stretchable microelectrodes | $861,339 | |
| Federal grant | Department of Health and Human Services · Phase II · A physiologically relevant pre-clinical drug screening platform for Alzheimer's Disease and Traumatic Brain Injury with integrated stretchable microelectrodes | $779,587 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1841 | Enable Biosciences Inc. | — | — |
| 1842 | Irenix Medical, Inc. | — | — |
| 1843 | CORAMIR BIOMEDICAL, INC. | — | — |
| 1844 | BMSEED, LLC | — | — |
| 1845 | SIL Technologies LLC | — | — |
| 1846 | NovApproach Spine, LLC | — | — |
| 1847 | MetalloPharm | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.